INFLUENZA. CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT, AND PREVENTION

Influenza is an infectious disease caused by RNA viruses. Influenza viruses are unique among respiratory viruses due to their antigenic variability, which allows them to "evade" human immune defenses and cause annual epidemics. This necessitates the yearly development of new influenza vaccines tailored to the circulating strains. It is precisely this phenomenon of antigenic variation that explains why influenza remains a major epidemic disease affecting humanity. Despite significant scientific and theoretical progress in the study of this infection, it continues to pose extremely serious challenges to public health. In this context, the recent human infections with the avian influenza virus, specifically strain A (H5N1) have heightened the risk of the emergence of an influenza virus with pandemic potential. This underscores the necessity for vaccination and a thorough understanding of the disease's clinical course and potential complications. Furthermore, it highlights the importance of rapid diagnosis and the timely administration of specific anti-influenza medications; these drugs are most therapeutically effective when administered within the first 48 hours of symptom onset. Influenza vaccination is primarily recommended for individuals at high risk of developing a severe or complicated form of the disease, as well as for their close contacts.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-17
DOI
https://doi.org/10.5281/zenodo.24323068
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

INFLUENZA. CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT, AND PREVENTION

Kahtan A.A.
2 links
Zenodo (CERN European Organization for Nuclear Research)
Influenza Virus Research Studies
article

INFLUENZA. CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT, AND PREVENTION

Kahtan A.A.
article en

Abstract

Influenza is an infectious disease caused by RNA viruses. Influenza viruses are unique among respiratory viruses due to their antigenic variability, which allows them to "evade" human immune defenses and cause annual epidemics. This necessitates the yearly development of new influenza vaccines tailored to the circulating strains. It is precisely this phenomenon of antigenic variation that explains why influenza remains a major epidemic disease affecting humanity. Despite significant scientific and theoretical progress in the study of this infection, it continues to pose extremely serious challenges to public health. In this context, the recent human infections with the avian influenza virus, specifically strain A (H5N1) have heightened the risk of the emergence of an influenza virus with pandemic potential. This underscores the necessity for vaccination and a thorough understanding of the disease's clinical course and potential complications. Furthermore, it highlights the importance of rapid diagnosis and the timely administration of specific anti-influenza medications; these drugs are most therapeutically effective when administered within the first 48 hours of symptom onset. Influenza vaccination is primarily recommended for individuals at high risk of developing a severe or complicated form of the disease, as well as for their close contacts.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon